Quick Take: atai Life Sciences (Nasdaq: ATAI) has closed on their initial public offering. issuing 15,000,000 common shares at a price of $15/share atai Life Sciences B.V. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the pricing of its upsized initial public offering in the United…